1. Home
  2. DOGZ vs CDXC Comparison

DOGZ vs CDXC Comparison

Compare DOGZ & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOGZ
  • CDXC
  • Stock Information
  • Founded
  • DOGZ 2003
  • CDXC 1999
  • Country
  • DOGZ China
  • CDXC United States
  • Employees
  • DOGZ N/A
  • CDXC N/A
  • Industry
  • DOGZ Miscellaneous manufacturing industries
  • CDXC Medicinal Chemicals and Botanical Products
  • Sector
  • DOGZ Consumer Discretionary
  • CDXC Health Care
  • Exchange
  • DOGZ Nasdaq
  • CDXC Nasdaq
  • Market Cap
  • DOGZ 547.0M
  • CDXC 449.5M
  • IPO Year
  • DOGZ 2017
  • CDXC N/A
  • Fundamental
  • Price
  • DOGZ $27.83
  • CDXC $5.42
  • Analyst Decision
  • DOGZ
  • CDXC Strong Buy
  • Analyst Count
  • DOGZ 0
  • CDXC 2
  • Target Price
  • DOGZ N/A
  • CDXC $8.00
  • AVG Volume (30 Days)
  • DOGZ 91.9K
  • CDXC 338.3K
  • Earning Date
  • DOGZ 03-04-2025
  • CDXC 03-05-2025
  • Dividend Yield
  • DOGZ N/A
  • CDXC N/A
  • EPS Growth
  • DOGZ N/A
  • CDXC N/A
  • EPS
  • DOGZ N/A
  • CDXC 0.02
  • Revenue
  • DOGZ $14,847,902.00
  • CDXC $91,668,000.00
  • Revenue This Year
  • DOGZ N/A
  • CDXC $18.64
  • Revenue Next Year
  • DOGZ N/A
  • CDXC $20.72
  • P/E Ratio
  • DOGZ N/A
  • CDXC $275.46
  • Revenue Growth
  • DOGZ N/A
  • CDXC 9.95
  • 52 Week Low
  • DOGZ $4.98
  • CDXC $1.48
  • 52 Week High
  • DOGZ $58.50
  • CDXC $7.97
  • Technical
  • Relative Strength Index (RSI)
  • DOGZ 40.77
  • CDXC 41.57
  • Support Level
  • DOGZ $27.21
  • CDXC $5.38
  • Resistance Level
  • DOGZ $33.98
  • CDXC $6.06
  • Average True Range (ATR)
  • DOGZ 3.56
  • CDXC 0.22
  • MACD
  • DOGZ -0.13
  • CDXC 0.00
  • Stochastic Oscillator
  • DOGZ 5.95
  • CDXC 5.88

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

Share on Social Networks: